Mega, TH0765010002

Mega stock reports 33.1 percent first half profit growth

Published on 10/05/2026 at 12:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mega stock heads into the November 12, 2026 results date after 1H26 revenue growth of 12.5 percent. EBITDA growth reached 33.8 percent as the SET quote was THB 33.50 on October 5.

Mega, TH0765010002, Illustration mit AI erstellt.
Mega, TH0765010002, Illustration mit AI erstellt.

Mega stock (ISIN TH0765010002) was last at THB 33.50 on the SET on October 5, 2026, at 4:39 p.m. ICT, down 0.74 percent from the previous close. The company is carrying a stronger operating profile into its next reporting date: Mega Lifesciences reported 12.5 percent growth in operating revenue for 1H26.

Profit growth leads the update

The same 1H26 update showed reported net profit growth of 33.1 percent year over year, while adjusted net profit grew 11.7 percent. The split matters because the reported result expanded faster than the adjusted measure, making the quality and composition of earnings an important point for the next quarterly release.

Mega Lifesciences also reported EBITDA growth of 33.8 percent in 1H26. Its gross profit represented 52.0 percent of operating revenue, while selling, general and administrative expenses represented 33.0 percent.

November date sets the checkpoint

The next company checkpoint is dated November 12, 2026, when Mega Lifesciences has scheduled its 3Q26 earnings announcement. The conference call is scheduled for November 13, 2026, giving investors two dated milestones for judging whether the first-half profit trend carried into the third quarter, according to Mega Lifesciences.

The operating-revenue increase of 12.5 percent is materially below the 33.8 percent EBITDA growth rate. That gap puts attention on margin development, expense control and the geographic mix of sales when the company publishes its next figures.

Stock remains below yearly high

Mega's THB 33.50 price on October 5, 2026, stood 16.25 percent below the 52-week high of THB 40.00 and THB 5.75 above the 52-week low of THB 27.75. The stock's market capitalization was THB 29.2 billion and volume was 340,600 shares on the same date.

For investors, the November results will connect the current valuation with the first-half operating record. The key comparison is whether revenue growth can move closer to the faster pace of EBITDA and reported net profit expansion.

Mega stock facts

  • Company: Mega Lifesciences Public Company Limited
  • ISIN: TH0765010002
  • Ticker: MEGA
  • Trading venue: SET
  • Price (as of October 5, 2026, 4:39 p.m. ICT): THB 33.50
  • Market capitalization: THB 29.2 billion (as of October 5, 2026)
  • 52-week range: THB 27.75-40.00 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic

Upcoming dates for Mega stock

  • November 12, 2026: 3Q26 earnings announcement
  • November 13, 2026: 3Q26 earnings conference call
  • December 1, 2026: Q3/2026 earnings call

More news and analyses on Mega stock

Disclaimer...

en | TH0765010002 | MEGA | boerse | 70232438 | bgmi